About Health Decisions
Health Decisions is a Healthcare company based in Durham (United States) founded in 1989, and was acquired by Premier Research in July 2021. CRO focused on clinical trial services for data management, monitoring and biostatistics. The company has 110 employees. Health Decisions offers products and services including Clinical Research Services, Regulatory Consulting, and Nonclinical Development. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services. Its legal entity is HEALTH DECISIONS, INC. Its competitors include SSI Strategy, Antios Therapeutics and Evidera; 1 of its 3 listed competitors has raised funding.
Company details
Health Decisions was established in 1989 in Durham, United States, as a contract research organization in the healthcare sector. Clinical trials are supported through specialized services in data management, site monitoring, and biostatistical analysis. Operations are centered on ensuring regulatory compliance and efficient trial execution for pharmaceutical and biotech clients across various therapeutic areas.
- Headquarters Durham, United States
- Employees 110
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website healthdec.com
- Social LinkedIn X
- Acquired by Premier Research (Jul 2021)
- Legal Name Health Decisions, Inc.
- Latest Funding Round$1.8M (USD), Unspecified
Apr 2018
- Investors
- Employee Count110
- Acquired byPremier Research
(Jul 2021)
Products & Services of Health Decisions
Health Decisions offers a comprehensive portfolio of products and services, including Clinical Research Services, Regulatory Consulting, and Nonclinical Development.
Services for conducting clinical trials and studies
Advice on product development and regulatory compliance
Support for pre-clinical testing and early phase work
Funding Insights of Health Decisions
- Total Rounds 1
- Last Round Unspecified — $1.8M
- First Round $1.8M
(Apr 2018)
All 1 funding rounds of Health Decisions with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2018 | $1.8M | Unspecified | – | – | – |
1 investors in total: 1 institutional.
Investors in Health Decisions
Health Decisions has secured backing from 1 investor. Prominent investors backing the company include Premier Research.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of clinical trial CRO services | 1989 | premier-research.com | Durham, United States |
Investor details for Health Decisions
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Health Decisions
98 people are tracked at Health Decisions (55 in leadership, 43 in team); the tracked headcount is 110.
| Name | Role | Group |
|---|---|---|
Josh Falletta | Executive Director, Business Development | Leadership |
Benjamin Spradley | Senior Director, Business Development | Leadership |
Ursula Cingolani | Director Of Business Development | Leadership |
Julie Knight | Senior Director, Strategic People Partner | Leadership |
Agnė Jasaitienė | Director Business Development | Leadership |
Daniel Oneill | Director Of Financial Reporting | Leadership |
Veronica Yildirim | Director, Business Development | Leadership |
Raphaela Schnurbus | Executive Director Business Development | Leadership |
Rob Lowrey | Vice President Finance / Controller | Leadership |
Heather Messenger | Vice President, Business Operations | Leadership |
Janet Kube | Executive Director, Program Delivery | Leadership |
Greg Meyer | VP, Regulatory Affairs | Leadership |
John Ratliff | CEO | Leadership |
Richard Shimota | CFO | Leadership |
Abie Ekangaki | VP, Statistical Consulting | Leadership |
Michael Edwards | Senior Director, Regulatory Affairs, MedTech, Premier Consulting | Leadership |
Mike Donovan | Vice President, Corporate Finance | Leadership |
Madeline Hallinger | Senior Director, Business Development | Leadership |
Michael Arlotto | COO | Leadership |
Reeves McGee | President, Consulting Division | Leadership |
78 more people are available in the full profile.
Complete people profiles for Health Decisions
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Health Decisions
3 dated milestones of Health Decisions across 32 years, from founding to its latest funding, stage changes and deals.
- Founded Health Decisions is founded.
- Funding First funding round of $1.8M.
- Exit Acquired by Premier Research.
Competitors of Health Decisions
Health Decisions has 3 listed competitors in our database, 1 of them funded. They include SSI Strategy, Antios Therapeutics and Evidera.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ssistrategy.com | 2010 | Parsippany Troy Hills, United States | Pharmacovigilance and medical affairs services are offered for drug development. | |||
| antiostherapeutics.com | 2018 | Atlanta, United States | $200.4M | Innovative therapies for treating and curing viral diseases are developed. | ||
| evidera.com | 2012 | Bethesda, United States | 304 | Evidence-based solutions are provided for biopharmaceutical real-world effectiveness and safety. |
Detailed competitors of Health Decisions
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Health Decisions
Websites that share an audience with Health Decisions (healthdec.com).
Websites whose visitors overlap most with Health Decisions. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| parexel.com | 100% | 220.8K | #203,256 | View details | |
bostonbio.com | bostonbio.com | 99% | – | ||
janix.com | janix.com | 64% | – | ||
| imarcresearch.com | 63% | 1.5K | #9,234,444 | View details | |
| monipol.com | 63% | View details | |||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 11 similar websites and full traffic analytics for Health Decisions
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 11 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Health Decisions (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Health Decisions
Complete news archive for Health Decisions
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Health Decisions
Health Decisions was founded in 1989 and raised its 1st funding round 29 years after it was founded.
Health Decisions is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Health Decisions has 110 employees.
Health Decisions was established in 1989 in Durham, United States, as a contract research organization in the healthcare sector. Clinical trials are supported through specialized services in data management, site monitoring, and biostatistical analysis. Operations are centered on ensuring regulatory compliance and efficient trial execution for pharmaceutical and biotech clients across various therapeutic areas.
Health Decisions's top competitors include SSI Strategy, Evidera and Antios Therapeutics.
Health Decisions offers Clinical Research Services, Regulatory Consulting, and Nonclinical Development.
Health Decisions has 1 investor. Key investors include Premier Research.
Health Decisions operates through Health Decisions, Inc..
Yes. Health Decisions was acquired by Premier Research in July 2021.